HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tran Dinh, Y. R. Articles by Seylaz, J. Search for Related Content PubMed PubMed Citation Articles by Tran Dinh, Y. R. Articles by Seylaz, J.

Cerebral Postischemic Hyperperfusion Assessed by Xenon-133 SPECT

Departments of Functional Nervous System Imaging, Neurology and Neuroradiology, Hôpital Lariboisière, Paris; Cerebrovascular Research Laboratory, CNRS UA 641, I.F.R Circulation-Lariboisière, Faculté de Médecine Lariboisière-Saint Louis, UniversitéParis VII, Paris; Department of Medicine,Hôpital de Mantes, Mantes la Jolie, France

Correspondence: For correspondence or reprints contact: Yves Roger Tran Dinh, MD, PhD, Laboratre de Recherches Cérébrovasculaires, C.N.R.S UA 641, I.F.R., Circulation-Lariboisière, Faculté de MédecineLariboisière-St Louis, 10 Avenue de Verdun, 75475 Paris, France.

ABSTRACT

In this study, the functional and clinical evolution of the cerebral postischemic hyperperfusion (CPH) were evaluated. Methods: Forty-four noncomatose patients suffering from unilateral cerebral ischemia located in the internal carotid territories were studied. Twenty-five consecutive patients having CPH with ¹³³Xe-SPECT cerebral blood flow (CBF) measurement and 19 patients without cerebral hyperperfusion matched for age. CBF, vasoreactivity to acetazol-amide and the evolution of the clinical state, scored by the National Institutes of Health scale for stroke, were compared. Results: CPH coincided with CT-scan abnormalities in 57% of cases. The mean cerebral vasoreactivity to acetazolamide was comparable in the two groups, but there was local vasoplegia in the hyperperfused areas in 20% of CPH patients, including two cases (8%) with a steal syndrome. Comparison of the initial and late clinical scores showed no significant difference between patients with and without CPH. For patients without CPH, the interhemispheric CBF asymmetry was correlated with the initial and the late scores (p < 0.0001,r = 0.81). For the CPH group, the interhemispheric asymmetry, compensated or even inverted by the hyperperfusion, was not correlated with the initial score (ns, p = 0.051 , r = 0.42)and was weakly correlated to the late score (p = 0.048, r = 0.43). Conclusion: The cerebral hemodynamics remain normal in 80% of cases of CPH patients. The presence of CPH does not interfere with the clinical evolution. The initial and late clinical scores were not different compared to those of patients without hyperperfusion. The clinical outcome of the CPH patients cannot be accurately predicted by the interhemispheric asymmetry.

Key Words: xenon-133 • SPECT • cerebral blood flow • cerebral postischemic hyperperfusion

This article has been cited by other articles:

				C. S. Kidwell, J. L. Saver, J. Mattiello, S. Starkman, F. Vinuela, G. Duckwiler, Y.P. Gobin, R. Jahan, P. Vespa, J. P. Villablanca, et al. Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans Neurology, December 11, 2001; 57(11): 2015 - 2021. [Abstract] [Full Text] [PDF]